SEC Form 4 · accession 0001127430-18-000061
INSMED Inc · INSM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William Lewis
Officer — President & CEO · Director
Period of report
Sep 28, 2018
Accepted (ET)
Oct 2, 2018 · 4:11 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001104506
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF1 | $12.44 | Sep 28, 2018 | A | 83,333 | A | Sep 28, 2018 | May 23, 2023 | Common Stock | 83,333 | 83,333 | D |
Explanation of responses
- F1On May 23, 2013, the reporting person was granted an option to purchase 166,667 shares of common stock. The option vests in two installments based upon the Issuer's satisfaction of two separate performance metrics. The first installment vested on February 26, 2015. The performance metric applicable to the second installment, the first written approval of a New Drug Application or Marketing Authorization Application from the Food and Drug Administration of European Medicines Agency, respectively, was met on September 28, 2018, resulting in the vesting of the second installment.